Showing chemical card for 3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid (CFc000167629)
3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid belongs to the class of organic compounds known as tetraterpenoids. These are terpenoid molecules containing 10 consecutively linked isoprene units. Based on a literature review very few articles have been published on 3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid.
MOL for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)
3D MOL for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)
3D SDF for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)
3D-SDF for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)
PDB for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)
3D PDB for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)
SMILES for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)
INCHI for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)
Structure for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)
3D Structure for CFc000167629 (3,4,5-trihydroxy-6-({4-[(1E,3E,5E,7E,9Z,11Z,13E)-14-{3-[(E)-2-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)ethenyl]-3-methyloxiran-2-yl}-3,7,12-trimethyltetradeca-1,3,5,7,9,11,13-heptaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxy)oxane-2-carboxylic acid)